Semaphorin 3 C is a Novel Adipokine Representing Exercise-Induced Improvements of Metabolism in Metabolically Healthy Obese Young Males
Open Access
- 19 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-10
- https://doi.org/10.1038/s41598-020-67004-7
Abstract
This study investigated the endurance exercise-induced changes in lesser known adipokines (visfatin, chemerin, apelin, semaphorin 3 C) related to obesity and metabolism, and their correlations with the changes in the parameters of obesity and glucose homeostasis. Forty metabolically healthy obese young males were randomly assigned to control group (C, n = 12) or exercise group (Ex, n = 28). The subjects in Ex participated in a 8-week supervised endurance exercise training program, comprised of four sessions of treadmill running at 65–70% of VO2max per week. Serum levels of visfatin, chemerin, apelin, and semaphorin 3 C were significantly decreased in Ex. At baseline, apelin and semaphorin 3 C appeared to be correlated with obesity measures, including body mass index, % total fat and trunk fat, and waist circumference. Exercise-induced changes in these obesity measures significantly correlated with the changes in chemerin and semaphorin 3 C. Basal chemerin, apelin and semaphorin 3 C correlated with glucose homeostasis parameters, including fasting plasma glucose, fasting plasma insulin, homeostasis model assessment of insulin resistance and β-cell function, and quantitative insulin-sensitivity check index to different extents. Furthermore, the changes in apelin and semaphorin 3 C well predicted the improvements in glycemic parameters. We suggest that semaphorin 3 C is a novel adipokine involved in pathophysiology of obesity and metabolism, and that it is a biomarker representing an exercise-induced improvement in metabolically healthy obese young males.This publication has 60 references indexed in Scilit:
- Aerobic exercise decreases chemerin/CMKLR1 in the serum and peripheral metabolic organs of obesity and diabetes rats by increasing PPARγNutrition & Metabolism, 2019
- The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCRBiochemistry and Cell Biology, 2014
- Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adultsThe journal of nutrition, health & aging, 2014
- Metabolically healthy obesity and risk of incident type 2 diabetes: a meta‐analysis of prospective cohort studiesObesity Reviews, 2014
- Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes MellitusPLOS ONE, 2012
- Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic β-cellsJournal of Molecular Endocrinology, 2009
- Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitroRegulatory Peptides, 2009
- Abdominal obesity and metabolic syndromeNature, 2006
- Serum Visfatin Increases With Progressive β-Cell DeteriorationDiabetes, 2006
- Methods of Estimation of Visceral Fat: Advantages of UltrasonographyObesity Research, 2003